KC1036 in ewing sarcoma: mechanistic insights and future directions for a multi-targeted therapeutic strategy
{{output}}
This letter aims to provide a forward-looking analysis of the recent preclinical study by Ou et al. (Angiogenesis, 2025) on the efficacy of the multi-kinase inhibitor KC1036 in Ewing sarcoma (ES).We conducted a critical appraisal of the reported data, focusing... ...
